Engineering mouse monoclonal antibodies for cancer immunotherapy.
Experimental Oncology E, Istituto Nazionale Tumori, Milan, Italy.
R
R
Orlandi
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use; D005803:Genes, Immunoglobulin; D006801:Humans; D007116:Immunization, Passive; D007127:Immunoglobulin Constant Regions / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000235:genetics; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D015202:Protein Engineering / Q000379:methods*; D011993:Recombinant Fusion Proteins / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use; D013045:Species Specificity; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007127:Immunoglobulin Constant Regions; D007135:Immunoglobulin Variable Region; D011993:Recombinant Fusion Proteins